全文获取类型
收费全文 | 2757篇 |
免费 | 203篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 91篇 |
妇产科学 | 27篇 |
基础医学 | 336篇 |
口腔科学 | 148篇 |
临床医学 | 340篇 |
内科学 | 601篇 |
皮肤病学 | 55篇 |
神经病学 | 208篇 |
特种医学 | 331篇 |
外科学 | 247篇 |
综合类 | 62篇 |
预防医学 | 169篇 |
眼科学 | 39篇 |
药学 | 269篇 |
中国医学 | 5篇 |
肿瘤学 | 101篇 |
出版年
2021年 | 27篇 |
2020年 | 24篇 |
2019年 | 29篇 |
2018年 | 36篇 |
2017年 | 26篇 |
2016年 | 29篇 |
2015年 | 41篇 |
2014年 | 52篇 |
2013年 | 79篇 |
2012年 | 102篇 |
2011年 | 80篇 |
2010年 | 80篇 |
2009年 | 77篇 |
2008年 | 84篇 |
2007年 | 159篇 |
2006年 | 93篇 |
2005年 | 110篇 |
2004年 | 86篇 |
2003年 | 101篇 |
2002年 | 81篇 |
2001年 | 87篇 |
2000年 | 75篇 |
1999年 | 81篇 |
1998年 | 89篇 |
1997年 | 92篇 |
1996年 | 62篇 |
1995年 | 82篇 |
1994年 | 57篇 |
1993年 | 56篇 |
1992年 | 54篇 |
1991年 | 73篇 |
1990年 | 48篇 |
1989年 | 89篇 |
1988年 | 67篇 |
1987年 | 56篇 |
1986年 | 63篇 |
1985年 | 77篇 |
1984年 | 52篇 |
1983年 | 42篇 |
1982年 | 34篇 |
1981年 | 33篇 |
1980年 | 43篇 |
1979年 | 31篇 |
1978年 | 24篇 |
1977年 | 29篇 |
1976年 | 24篇 |
1975年 | 18篇 |
1974年 | 11篇 |
1973年 | 19篇 |
1970年 | 13篇 |
排序方式: 共有3043条查询结果,搜索用时 15 毫秒
61.
62.
Headless compression screw fixation prevents symptomatic metalwork in arthroscopic ankle arthrodesis
BackgroundArthroscopic ankle arthrodesis (AAA) is a recognised salvage procedure for end-stage arthritis. Its reported disadvantages include a high rate of re-operation for symptomatic prominence of metalwork. We propose that the use of a headless screw would reduce this re-operation rate.MethodsWe reviewed 32 AAAs, using the Acutrak?6/7 mm headless screw fixation system, to determine peri-operative parameters and complication rates.ResultsAt an average of 22 months follow-up, 28 (88%) had united radiologically. There were 2 stable fibrous non-unions not requiring further intervention. Of the other 2, one was successfully revised using an open technique, and the other patient died of unrelated causes.There were no other complications in this series, with no cases of metalwork removal for prominence or pain.ConclusionsUsing a headless screw fixation for arthroscopic ankle arthrodesis prevents symptomatic metalwork prominence and the requirement for removal. 相似文献
63.
64.
Tamar Mendelson Steven C. Sheridan Laura K. Clary 《Research in social & administrative pharmacy》2021,17(6):1110-1118
BackgroundYouth of color from low-income urban communities are crucial participants in research, as their involvement can shape effective, culturally responsive interventions and policy to promote youth health and well-being. These young people, however, are an often-neglected research population, due in part to perceived challenges associated with their inclusion as well as marginalized communities’ justifiable mistrust of research.ObjectivesBased on our experience conducting a school-based randomized intervention trial in Baltimore, Maryland, we present strategies for conducting research with low-income, urban youth of color. We discuss strategies in three domains: university-community partnership development, participant recruitment, and participant retention.MethodsWe reviewed partnership building and recruitment strategies employed by our team across four years of trial implementation and evaluated success of participant retention at our final survey timepoint.ResultsPartnership building was facilitated by selection of a study design that maximized benefits for all participants, promotion of capacity building at partner institutions, and attention to research staff hiring and training practices. Effective study recruitment strategies included personal contact with parents and close cooperation between school personnel and study staff. Providing incentives and collecting multiple types of participant contact information contributed to increased retention rates. On average, those who participated in the final survey timepoint were less likely to be male and Latinx and exhibited more favorable baseline mental health than those who did not, suggesting differential attrition based on youth characteristics.ConclusionsLessons learned from this school-based trial can be applied more broadly to research with low-income urban youth of color. Researchers should strive to maximize scientific rigor, minimize harm to vulnerable adolescents and their communities, promote positive research experiences for young people, and provide concrete benefits to those who participate. 相似文献
65.
66.
S. Wayne Miles Janie Sheridan Bruce Russell Rob Kydd Amanda Wheeler Carina Walters Greg Gamble Peta Hardley Maree Jensen Kimmo Kuoppasalmi Pekka Tuomola Jaana Föhr Outi Kuikanmäki Helena Vorma Raimo Salokangas Antti Mikkonen Mika Kallio Jussi Kauhanen Vesa Kiviniemi Jari Tiihonen 《Addiction (Abingdon, England)》2013,108(7):1279-1286
67.
Kathryn M King Tracey JF Colella Peter Faris David R Thompson 《Journal of clinical nursing》2009,18(11):1617-1624
Aims. To examine the utility and validate the use of the Cardiac Depression Scale in patients who had first‐time coronary artery bypass graft surgery. Background. The Beck Depression Inventory, though frequently used, may not be sufficiently sensitive for use in cardiac patients. The Cardiac Depression Scale has been shown to identify the range of depression in medical cardiac patients. Design. Survey. Methods. The Beck Depression Inventory and Cardiac Depression Scale were administered to 120 men at hospital discharge, as well as six, 12 and 36 weeks postoperatively. Cronbach’s α scores were calculated for the measures at each point. Changes in scores over time were analysed using repeated measures analysis of variance. Associations between the measures scores were calculated using Pearson product–moment correlations. Agreement between the measures’ dichotomised scores (depression/no depression) was examined using Cohen’s Kappa statistic. Results. Internal consistency was similar for the Beck Depression Inventory (0·793–0·904) and Cardiac Depression Scale (0·859–0·910). Depression scores decreased over time with the Beck Depression Inventory [F(2·50, 175·29) = 22·27, p < 0·001] and Cardiac Depression Scale [F(2·68, 190·37) = 13·18, p < 0·001]. The measures had similar power [Cohen’s f = 0·65 (Beck Depression Inventory) and 0·43 (Cardiac Depression Scale)] to reveal changes over time. The continuous scores were highly correlated at each point [0·737 (p < 0·001)–0·819 (p < 0·001)]. However, when dichotomised scores were compared, the chance corrected level of agreement was less impressive [0·198 (p = 0·014)–0·381 (p < 0·001)]. Conclusions. The Cardiac Depression Scale may have utility for use with surgical cardiac patients. However, continued examination of this measure of depression is warranted. Relevance to clinical practice. Given the prevalence of depression and its negative impact on coronary artery disease, it is important to identify even mild depression in cardiac patients. Using a measure of depression specifically for cardiac patients, rather than a generic measure, may best accomplish this goal. 相似文献
68.
José T Ortiz-Pérez Sheridan N Meyers Daniel C Lee Preeti Kansal Francis J Klocke Thomas A Holly Charles J Davidson Robert O Bonow Edwin Wu 《European heart journal》2007,28(14):1750-1758
AIMS: Global angiographic scores have been developed to determine the extent of myocardium jeopardized by significant coronary stenosis. We adapted these scores to quantify the anatomic area at risk during acute myocardial infarction. We used contrast-enhanced magnetic resonance (CMR) infarct imaging to measure the portion of myocardium that developed necrosis within the so defined angiographic area at risk. METHODS AND RESULTS: In 83 subjects presenting for primary percutaneous intervention, the myocardium at risk was estimated angiographically using the Myocardial Jeopardy Index (BARI) and a modified version of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) scores. CMR was performed within a week to measure infarct size, infarct endocardial surface area (infarct-ESA), and infarct transmurality. As infarct transmurality increased, the infarct size closely approximated the myocardium at risk by angiography. In 35 subjects with transmural infarcts, the area at risk by BARI and APPROACH scores matched the infarct size (r = 0.90 and r = 0.92, P < 0.001). Additionally, BARI and APPROACH scores matched the infarct-ESA in all subjects independently of collateral flow and time to reperfusion (r = 0.90 and r = 0.87, P < 0.001). The presence of early reperfusion, collaterals, or both was associated with a progressive decrease in infarct transmurality (P < 0.001 for trend) with no difference in the infarct-ESA. CONCLUSION: The myocardium at risk of infarction can be determined angiographically as validated in subjects with transmural myocardial infarcts. Salvage provided by early reperfusion or collaterals occurs by limiting infarct transmurality, thereby the extent of endocardial infarct involved also allows estimation of the myocardium at risk in patients presenting with STEMI. 相似文献
69.
Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop 总被引:5,自引:1,他引:5
Gu ZJ; Costes V; Lu ZY; Zhang XG; Pitard V; Moreau JF; Bataille R; Wijdenes J; Rossi JF; Klein B 《Blood》1996,88(10):3972-3986
We have a previously reported that interleukin-10 (IL-10) is a potent but IL-6-unrelated growth factor for freshly explanted myeloma cells (Lu et al, Blood 85:2521, 1995). We have also shown that exogenous IL- 10 supported the growth of XG-1 and XG-2 human myeloma cell lines (HMCL) through an IL-6-independent mechanism. (Lu et al, Blood 85:2521, 1995). Because the IL-10 receptor does not involve the gp 130 IL-6 transducer, we have attempted to elucidate the mechanisms of IL-10 action on myeloma cells. Our results indicate that the myeloma cell growth factor activity of IL-10 was abrogated by an antibody to the gp 130 IL-6 transducer, indicating that it was mediated through one of the gp 130-activating cytokines. We found that myeloma cells from XG-1 and XG-2 HMCL and from 5 of 6 patients' tumoral samples produced oncostatin M (OM) constitutively but failed to produce IL-6, IL-11 and leukemia- inhibitory factor (LIF). The autocrine OM was inactive in the absence of IL-10 due to lack of a functional OM receptor on myeloma cells. IL- 10, by inducing the receptor for LIF (LIFR), produced a functional autocrine OM loop in XG-1 and XG-2 cells and in primary myeloma cells from 2 patients. We also found that some myeloma cell lines (XG-4, XG- 6, and XG-7) an fresh myeloma cells from 3 of 6 patients produced an autocrine IL-10 and that these cells constitutively expressed LIFR. One HMCL (XG-7) produced IL-10, OM, and IL-6 an expressed LIFR. The XG-7 cells used OM and IL-6 as autocrine growth factors. We have previously shown that IL-10 could induce IL-11 receptor in myeloma cells and confer on them sensitivity to IL-11 (Lu et al, FEBS Lett 377:515, 1995). Taken together, these results show that IL-10 is a key cytokine for inducing the expression of LIFR and IL-11R and possibly another uncharacterized OM coreceptor on myeloma cells and that OM and IL-10 might be produced by myeloma cells. They also emphasize that all myeloma cell growth factors reported to data involve an activation of the gp130 IL-6 transducer. 相似文献
70.
Human cytomegalovirus increases constitutive production of interleukin- 6 and leukemia inhibitory factor by bone marrow stromal cells 总被引:7,自引:0,他引:7
Lagneaux L; Delforge A; Snoeck R; Bosmans E; Moreau JF; Taupin JL; De Clercq E; Stryckmans P; Bron D 《Blood》1996,87(1):59-66
Human cytomegalovirus (CMV) infection is often associated with myelosuppression and acute inflammatory reaction in immunocompromised patients. We have previously documented that CMV exposure of bone marrow (BM) stromal cells reduces the capacity of these cells to support hematopoiesis because of a decreased production of colony- stimulating factors. This study examines the potential role of CMV on constitutive and lipopolysaccharide (LPS)-stimulated production of cytokines involved in inflammatory reaction, interleukin-6 (IL-6) and leukemia inhibitory factor (LIF) by BM stromal cells. The release of IL- 6 was already detectable 2 hours post CMV-infection (2.5-fold increase in production) and the cumulative production of IL-6 after 5 days of infection was 23 +/- 1.2 ng/mL (ninefold increase in production). CMV was also able to induce a time-dependent production of LIF that was maximal 8 hours after CMV infection (2.5-fold increase in production). Concomitantly, there was no detectable release of granulocyte colony- stimulating factor (G-CSF) and granulocyte-macrophage CSF (GM-CSF) by CMV-infected stromal cells. The similar IL-6 and LIF production in the presence of polymyxin B ruled out the possibility that this increase could be caused by contamination of the viral stock by endotoxin. In addition, ultraviolet-inactivated virus behaved similarly to live virus and caused the release of IL-6 and LIF. However, heat-inactivated CMV was unable to induce IL-6 and LIF secretion by BM stromal cells. The production of IL-6 and LIF was also evaluated after stimulation by LPS. After 5 days of CMV exposure, the LPS-stimulated production of IL-6 and LIF was significantly lower than uninfected controls. This LPS-induced release of cytokine production was found to be dependent of viral replication. The experiments have shown that CMV is a potent inducer of IL-6 and LIF with differential effect on constitutive and LPS- stimulated cytokine production by stromal cells; we suggest that CMV induction of IL-6 and LIF during the first hours of infection could play a role in CMV-induced inflammatory reaction. Moreover, our results show that human CMV can disturb the balanced cytokine network involved in the regulation of hematopoiesis. 相似文献